From $8.1 Billion to $38 Billion: The Explosive Growth Journey of the Antibody Drug Conjugates Market
The advancement of precision medicine has significantly transformed oncology treatment approaches, enabling the development of therapies that selectively target cancer cells while minimizing damage to healthy tissues.
